StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) stock

ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

Estrella Immunopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Estrella Immunopharma's price to book ratio was 6.1× on Jul 31, 2026, against 7.2× a year earlier. Over the last 3 years it ranged from 3.9× to 20.7×, with a median of 8.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20266.1×−7.2
2025Dec 31, 202513.4×+3.1
2024Dec 31, 202410.3×+6.4
2023Dec 29, 20233.9×–

More Estrella Immunopharma figures

See a number that looks wrong?